Skip to main content
. 2011 Nov 8;2(4):209–261. doi: 10.1007/s13539-011-0045-3
  NC S PC C RC
  n = 50 n = 10 n = 29 n = 49 n = 70
ECOG PS* (0-4; 4worst) 0.7 ± 1.0^ 0.6 ± 0.5 1.1 ± 0.3 1.2 ± 0.7 2.5 ± 0.8
McGill QoL Total Score (0-10; 0 Worst)** 7.0 ± 1.2 7.2 ± 1.0 5.2 ± 1.3 5.3 ± 1.5 4.9 ± 1.5
# Hospital days/follow-up days(%)*** 4.6 ± 11.2 6.1 ± 13.9 13.5 ± 25.5 4.9 ± 11.6 30.8 ± 35.8
Chemotherapy Dose Reduction† 4/17 (23.5%) 1/1 (100%) 3/9 (33.3%) 7/16 (43.8%) 8/16 (50%)
Total fat mass by DXA (kg) †† 26.1 ± 11.7 19.8 ± 10.9 19.9 ± 10.7 17.1 ± 9.4 13.0 ± 7.6
Total lean mass by DXA (kg) ‡ 10.9 ± 2.1 7.3 ± 2.3 10.3 ± 2.8 8.3 ± 1.7 9.6 ± 2.2
Survival (wks) ‡‡ 69.4 62.8 35.0 39.4 11.1
Median (95% CI) (48.1–90.8) (42.5–83.2) (13.9–56.1) (28.4–50.4) (5.9–16.3)